MedTrace Logo

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

NCT07297940 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-03-31

No results posted yet for this study

Summary

This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fasting state.

Conditions

  • Healthy

Interventions

DRUG

DA-1229_01

single dose administration (DA-1229 one tablet once a day)

DRUG

DA-1229_01-R

single dose administration (DA-1229\_01-R one tablet once a day)

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-14
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07297940 on ClinicalTrials.gov